MYLAN 217 250 (Tolazamide 250 mg)

Pill imprint MYLAN 217 250 has been identified as Tolazamide 250 mg.

Tolazamide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Tolazamide 250 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for MYLAN 217 250

Tolazamide 250 mg MYLAN 217 250 Front
Tolazamide 250 mg MYLAN 217 250 Back
Tolazamide 250 mg MYLAN 217 250
Tolazamide
Imprint:
MYLAN 217
250
Strength:
250 mg
Color:
White
Size:
10.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Sulfonylureas
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-0217
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)